Universe Pharmaceuticals is a small China-based pharmaceutical company that manufactures and sells Traditional Chinese Medicine-derived (TCMD) products, primarily targeting elderly consumers managing chronic conditions like fatigue, joint pain, arthritis, and poor circulation. The company's flagship product, Guben Yanling Pill, accounted for roughly 43% of FY25 revenue and is the clearest driver of the business. Other own-manufactured products include medicinal liquors, syrups, and pill formulations for chronic conditions, as well as cold and flu medicines. Own TCMD products represent about 74% of FY25 revenue. The remaining ~26% comes from a third-party distribution business, run through subsidiary Universe Trade, which resells biochemical drugs, Traditional Chinese Medicine Pieces, and medical instruments sourced from other manufacturers — a lower-margin, declining segment. Universe Pharmaceuticals sells to distributors, hospitals, clinics, and drugstore chains across 30 provinces in China, with no single customer exceeding 10% of revenue. The company's core strength is concentrated in Jiangxi Province. Universe Pharmaceuticals is investing in national brand building under the "Bai Nian Dan" brand through TV and digital advertising, expanding its distribution network beyond southern China, building new manufacturing capacity, and developing new TCMD products targeting elderly consumers in immunity and sleep.